Kestra Advisory Services »

Tscan Therapeutics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $63k 63k 1.01

More positions owned by Kestra Advisory Services

Apple (AAPL)
Parker-Hannifin Corporation (PH)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
First Tr Exchange Traded Risng Divd Achiv (RDVY)

View all positions for Kestra Advisory Services

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
BVF
Baker Bros. Advisors
Vanguard Group
Vanguard Capital Management
BlackRock
Millennium Management
Deer Management
Two Sigma Investments
Renaissance Technologies
Standard Life Aberdeen
Jacobs Levy Equity Management
DC Funds
Geode Capital Management
GSA Capital Partners

View all funds holding Tscan Therapeutics